Dr. David J. Bearss, CEO, will partake in a panel focused on Neurodegenerative Disease Targets and Pipelines on Tuesday, October 15 at 11:00-11:50 am PT LEHI, Utah, Oct. 14, 2024 /PRNewswire/ --...

Data show more patients treated with mirikizumab achieved histologic response at Week 52 compared to ustekinumab New data are first-of-its-kind analysis of microscopic mucosal resolution that go...

Canton Fair has unveiled a new mobile app designed to enhance the convenience and efficiency of the event. This development is part of the organizer's aim to build an all-year-round Canton Fair...

Showcasing the Industry's Only Next-Generation Battery Pack in Partnership with FEV Group for Automotive Applications PARIS, Oct. 14, 2024 /PRNewswire/ -- ProLogium Technology, the global leader...

BioCity Biopharma announced that a late-breaking clinical trial abstract of its endothelin receptor type A (ETA) selective antagonist SC0062 has been selected for oral presentation at ASN Kidney...